"The Most Critical Metal for Global Economies"
The soaring demand for this "red rock" may be the most important development in 2022. It's key in the transition to the new green energy economies. Bloomberg News warns… "Within a decade, the world may face a massive shortfall of what's arguably the most critical metal for global economies." Copper prices have nearly doubled in the past year.
Find Out How This Is Good News

CMPI Insider Trading (Checkmate Pharmaceuticals)

Insider Ownership Percentage: 6.30%
Insider Buying (Last 12 Months): $43,632.96
Insider Selling (Last 12 Months): $9,168,712.64

Checkmate Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Checkmate Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Checkmate Pharmaceuticals Share Price & Price History

Current Price: $10.45
Price Change: Price Increase of +0.01 (0.10%)
As of 05/16/2022 04:07 PM ET

This chart shows the closing price history over time for CMPI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

Checkmate Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2022Global Strategic Fund I VenbioMajor ShareholderSell17,700$10.38$183,726.002,412,105View SEC Filing Icon  
5/9/2022Global Strategic Fund I VenbioMajor ShareholderSell17,600$10.37$182,512.002,448,481View SEC Filing Icon  
5/6/2022Global Strategic Fund I VenbioMajor ShareholderSell48,334$10.37$501,223.582,466,081View SEC Filing Icon  
5/4/2022Global Strategic Fund I VenbioMajor ShareholderSell37,500$10.37$388,875.002,535,158View SEC Filing Icon  
5/2/2022Global Strategic Fund I VenbioMajor ShareholderSell153,700$10.38$1,595,406.002,652,133View SEC Filing Icon  
4/29/2022Global Strategic Fund I VenbioMajor ShareholderSell69,230$10.38$718,607.402,805,833View SEC Filing Icon  
4/27/2022Global Strategic Fund I VenbioMajor ShareholderSell47,396$10.38$491,970.482,948,463View SEC Filing Icon  
4/25/2022Global Strategic Fund I VenbioMajor ShareholderSell27,668$10.39$287,470.523,060,542View SEC Filing Icon  
4/21/2022Global Strategic Fund I VenbioMajor ShareholderSell62,200$10.38$645,636.003,125,640View SEC Filing Icon  
4/19/2022Global Strategic Fund I VenbioMajor ShareholderSell399,923$10.42$4,167,197.663,273,451View SEC Filing Icon  
2/25/2022Holdings A/S NovoMajor ShareholderSell300$2.70$810.00View SEC Filing Icon  
2/23/2022Holdings A/S NovoMajor ShareholderSell1,820$2.90$5,278.00View SEC Filing Icon  
6/18/2021Arthur M. KriegInsiderBuy7,224$6.04$43,632.96815,734View SEC Filing Icon  
3/25/2021Arthur M. KriegInsiderBuy10,036$12.35$123,944.60743,227View SEC Filing Icon  
1/27/2021Arthur M. KriegInsiderBuy1,701$13.05$22,198.05733,191View SEC Filing Icon  
1/19/2021Arthur M. KriegInsiderBuy500$13.09$6,545.00731,490View SEC Filing Icon  
12/29/2020Arthur M. KriegInsiderBuy443$14.16$6,272.88730,990View SEC Filing Icon  
12/15/2020Arthur M. KriegInsiderBuy42$14.49$608.58720,639View SEC Filing Icon  
See Full Table
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Checkmate Pharmaceuticals (NASDAQ:CMPI)

74.56% of Checkmate Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CMPI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Checkmate Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022Novo Holdings A S2,161,990$6.90M0.3%-0.4%9.818%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.556,423$1.78M0.0%-4.0%2.527%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.51,334$0.16M0.0%-2.0%0.233%Search for SEC Filing on Google Icon
5/10/2022Decheng Capital Management III Cayman LLC1,333,254$4.25M1.3%N/A6.055%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC10,633$31K0.0%N/A0.049%Search for SEC Filing on Google Icon
2/14/2022Clough Capital Partners L P1,306,626$3.75M0.3%-16.6%6.041%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc93,334$0.27M0.0%-22.2%0.431%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.51,794$0.21M0.0%+126.7%0.239%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC40,422$0.24M0.0%N/A0.187%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC21,500$0.13M0.0%-69.9%0.099%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE6,331$37K0.0%-38.9%0.029%Search for SEC Filing on Google Icon
8/16/2021Alberta Investment Management Corp25,000$0.15M0.0%N/A0.116%Search for SEC Filing on Google Icon
8/16/2021Federated Hermes Inc.16,169$96K0.0%-40.0%0.075%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC23,500$0.14M0.0%N/A0.109%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC40,272$0.24M0.0%-61.1%0.186%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.336,587$2.01M0.0%-10.5%1.556%Search for SEC Filing on Google Icon
8/12/2021Advisory Services Network LLC7,800$46K0.0%N/A0.036%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.5,157$31K0.0%-79.5%0.024%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC26,427$0.16M0.0%N/A0.122%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG134,760$0.80M0.0%-2.3%0.623%Search for SEC Filing on Google Icon
5/18/2021Canada Pension Plan Investment Board10,000$0.12M0.0%-33.3%0.046%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System13,503$0.16M0.0%+76.8%0.062%Search for SEC Filing on Google Icon
5/14/2021Sectoral Asset Management Inc541,766$6.58M0.5%-1.3%2.505%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp81,359$0.99M0.0%+34.0%0.376%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC103,425$1.26M0.0%+180.8%0.478%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.25,117$0.31M0.0%+91.8%0.116%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.368,226$4.47M0.0%+49.7%1.703%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.5,217$63K0.0%+77.8%0.024%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio19,300$0.23M0.0%+865.0%0.089%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.13,092$0.19M0.0%+595.6%0.061%Search for SEC Filing on Google Icon
2/17/2021Canada Pension Plan Investment Board15,000$0.22M0.0%-50.0%0.070%Search for SEC Filing on Google Icon
2/16/2021Clough Capital Partners L P1,332,397$19.35M1.4%+1.5%6.183%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.26,950$0.39M0.0%-46.1%0.125%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp60,738$0.89M0.0%+9.2%0.282%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN2,707$39K0.0%+92.8%0.013%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp17,436$0.25M0.0%N/A0.081%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.245,999$3.59M0.0%-0.8%1.141%Search for SEC Filing on Google Icon
1/25/2021Strs Ohio2,000$29K0.0%+53.8%0.009%Search for SEC Filing on Google Icon
11/17/2020Clough Capital Partners L P1,313,286$14.86M1.1%N/A6.095%Search for SEC Filing on Google Icon
11/17/2020California State Teachers Retirement System7,639$88K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/13/2020Sofinnova Investments Inc.3,606,707$41.51M3.1%N/A16.739%Search for SEC Filing on Google Icon
11/12/2020Federated Hermes Inc.50,000$0.58M0.0%N/A0.232%Search for SEC Filing on Google Icon
11/10/2020State Street Corp39,045$0.45M0.0%N/A0.181%Search for SEC Filing on Google Icon
11/9/2020Caas Capital Management LP44,966$0.52M0.0%N/A0.209%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.247,921$2.85M0.0%N/A1.151%Search for SEC Filing on Google Icon
11/5/2020New York State Common Retirement Fund4,658$54K0.0%N/A0.022%Search for SEC Filing on Google Icon
11/4/2020American International Group Inc.3,019$35K0.0%N/A0.014%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Checkmate Pharmaceuticals logo
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Read More on Checkmate Pharmaceuticals

Today's Range

Now: $10.45
Low: $10.45
High: $10.46

50 Day Range

MA: $5.83
Low: $2.41
High: $10.44

52 Week Range

Now: $10.45
Low: $2.00
High: $10.48

Volume

6,918 shs

Average Volume

138,253 shs

Market Capitalization

$230.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Checkmate Pharmaceuticals?

Checkmate Pharmaceuticals' top insider shareholders include:
  1. Global Strategic Fund I Venbio (Major Shareholder)
  2. Arthur M Krieg (Insider)
  3. Holdings A/S Novo (Major Shareholder)
Learn More about top insider investors at Checkmate Pharmaceuticals.

Who are the major institutional investors of Checkmate Pharmaceuticals?

Checkmate Pharmaceuticals' top institutional investors include:
  1. Novo Holdings A S — 9.82%
  2. Decheng Capital Management III Cayman LLC — 6.05%
  3. Vanguard Group Inc. — 2.53%
  4. BlackRock Inc. — 0.23%
Learn More about top institutional investors of Checkmate Pharmaceuticals stock.

Which institutional investors are selling Checkmate Pharmaceuticals stock?

In the previous quarter, CMPI stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. Novo Holdings A S
  3. BlackRock Inc.
During the previous year, company insiders that have sold Checkmate Pharmaceuticals company stock include:
  1. Global Strategic Fund I Venbio (Major Shareholder)
  2. Arthur M Krieg (Insider)
Learn More investors selling Checkmate Pharmaceuticals stock.

Which institutional investors are buying Checkmate Pharmaceuticals stock?

During the previous quarter, CMPI stock was bought by institutional investors including:
  1. Decheng Capital Management III Cayman LLC
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.